Medtronic (MDT) Reports Strong Real World Ablation Data At APHRS 2026

Medtronic (NYSE:MDT) reported positive real world registry results for its Sphere-9 catheter and PulseSelect PFA System at APHRS 2026. The Sphere-9 catheter data covered both atrial and ventricular arrhythmias, with registry outcomes indicating high procedural success rates. PulseSelect PFA System findings highlighted a strong safety profile in everyday clinical use, beyond controlled trial settings. The Sphere-9 and PulseSelect registry findings matter, but investors should weigh more than...